(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GPX2 mRNA] CTD PMID:31150632 (R)-lipoic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in increased expression of GPX2 mRNA CTD PMID:23830814 (S)-naringenin multiple interactions ISO RGD:1345750 6480464 [Paraquat co-treated with naringenin] results in increased expression of GPX2 mRNA CTD PMID:24561720 (S)-naringenin increases expression ISO RGD:1345750 6480464 naringenin results in increased expression of GPX2 mRNA CTD PMID:24561720 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression EXP 6480464 o, p'-DDT affects the expression of GPX2 mRNA CTD PMID:17984292 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of GPX2 mRNA CTD PMID:32387197 1,2-dimethylhydrazine increases expression ISO RGD:735351 6480464 1, 2-Dimethylhydrazine results in increased expression of GPX2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:735351 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of GPX2 mRNA] CTD PMID:22206623 1-chloro-2,4-dinitrobenzene affects expression ISO RGD:735351 6480464 Dinitrochlorobenzene affects the expression of GPX2 mRNA CTD PMID:28219650 1-chloro-2,4-dinitrobenzene multiple interactions ISO RGD:735351 6480464 NFE2L2 protein promotes the reaction [Dinitrochlorobenzene results in increased expression of GPX2 mRNA] CTD PMID:28219650 1-naphthyl isothiocyanate multiple interactions ISO RGD:735351 6480464 [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of GPX2 mRNA more ... CTD PMID:30517764 , PMID:33749747 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of GPX2 mRNA CTD PMID:30723492 1-naphthyl isothiocyanate increases expression ISO RGD:735351 6480464 1-Naphthylisothiocyanate results in increased expression of GPX2 mRNA CTD PMID:30517764 , PMID:33749747 17alpha-ethynylestradiol multiple interactions ISO RGD:735351 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GPX2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of GPX2 mRNA CTD PMID:15576828 more ... 17beta-estradiol multiple interactions ISO RGD:1345750 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of GPX2 mRNA more ... CTD PMID:17404688 more ... 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPX2 mRNA CTD PMID:32741896 17beta-estradiol increases expression ISO RGD:1345750 6480464 Estradiol results in increased expression of GPX2 mRNA CTD PMID:19619570 , PMID:21185374 17beta-estradiol decreases expression ISO RGD:1345750 6480464 Estradiol results in decreased expression of GPX2 mRNA CTD PMID:20106945 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPX2 mRNA CTD PMID:32741896 1H-pyrazole increases expression ISO RGD:735351 6480464 pyrazole results in increased expression of GPX2 mRNA CTD PMID:17945193 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO RGD:735351 6480464 2 more ... CTD PMID:20005886 , PMID:21851831 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:735351 6480464 Tetrachlorodibenzodioxin promotes the reaction [2 more ... CTD PMID:21851831 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1345750 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of GPX2 mRNA, [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of GPX2 mRNA CTD PMID:19619570 , PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:735351 6480464 Tetrachlorodibenzodioxin results in decreased expression of GPX2 mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:735351 6480464 Tetrachlorodibenzodioxin affects the expression of GPX2 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GPX2 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1345750 6480464 Tetrachlorodibenzodioxin results in increased expression of GPX2 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:735351 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GPX2 mRNA more ... CTD PMID:17942748 , PMID:21851831 2,4,6-trinitrobenzenesulfonic acid decreases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of GPX2 mRNA CTD PMID:31669340 2-acetamidofluorene multiple interactions EXP 6480464 [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA, [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GPX2 mRNA CTD PMID:14656948 , PMID:16158176 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:34256052 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 AHR gene mutant form inhibits the reaction [3 more ... CTD PMID:34256052 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1345750 6480464 tetrabromobisphenol A results in increased expression of GPX2 mRNA CTD PMID:31326446 3,4-methylenedioxymethamphetamine increases expression ISO RGD:735351 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of GPX2 mRNA CTD PMID:20188158 3,7-dihydropurine-6-thione increases expression ISO RGD:1345750 6480464 Mercaptopurine results in increased expression of GPX2 mRNA CTD PMID:18222062 3-phenylprop-2-enal multiple interactions ISO RGD:735351 6480464 NFE2L2 protein promotes the reaction [cinnamaldehyde results in increased expression of GPX2 mRNA] CTD PMID:28219650 3-phenylprop-2-enal affects expression ISO RGD:735351 6480464 cinnamaldehyde affects the expression of GPX2 mRNA CTD PMID:28219650 3-phenylprop-2-enal increases expression ISO RGD:1345750 6480464 cinnamaldehyde results in increased expression of GPX2 mRNA CTD PMID:19000754 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1, 2-dithiol-3-thione results in increased expression of GPX2 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of GPX2 mRNA CTD PMID:30723492 4,4'-sulfonyldiphenol decreases expression ISO RGD:735351 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of GPX2 mRNA CTD PMID:30951980 4-hydroxy-TEMPO multiple interactions ISO RGD:735351 6480464 [tempol co-treated with Tobacco Smoke Pollution] results in increased expression of GPX2 mRNA, tempol promotes the reaction [Tobacco Smoke Pollution results in increased expression of GPX2 protein] CTD PMID:32726580 4-hydroxynon-2-enal decreases expression ISO RGD:1345750 6480464 4-hydroxy-2-nonenal results in decreased expression of GPX2 mRNA CTD PMID:12419474 4-hydroxyphenyl retinamide increases expression ISO RGD:1345750 6480464 Fenretinide results in increased expression of GPX2 mRNA CTD PMID:15623509 4-nitroquinoline N-oxide multiple interactions ISO RGD:1345750 6480464 Glucose inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of GPX2 protein] CTD PMID:32942007 5-fluorouracil multiple interactions ISO RGD:1345750 6480464 TP53 protein affects the reaction [Fluorouracil results in decreased expression of GPX2 mRNA] CTD PMID:15016801 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions EXP 6480464 [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA CTD PMID:22687989 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of GPX2 mRNA CTD PMID:24780913 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:18056462 7,9-dihydro-1H-purine-2,6,8(3H)-trione multiple interactions ISO RGD:735351 6480464 [1-Naphthylisothiocyanate co-treated with Uric Acid] results in increased expression of GPX2 mRNA CTD PMID:33749747 9-cis-retinoic acid increases expression ISO RGD:1345750 6480464 Alitretinoin results in increased expression of GPX2 mRNA CTD PMID:15623509 acetamide increases expression EXP 6480464 acetamide results in increased expression of GPX2 mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of GPX2 mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:1345750 6480464 Aflatoxin B1 affects the expression of GPX2 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of GPX2 mRNA CTD PMID:23385219 more ... aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of GPX2 mRNA CTD PMID:28027979 aldehydo-D-glucose multiple interactions ISO RGD:1345750 6480464 Glucose inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of GPX2 protein] CTD PMID:32942007 all-trans-retinoic acid multiple interactions ISO RGD:1345750 6480464 [Tretinoin co-treated with Ascorbic Acid] results in increased expression of GPX2 mRNA CTD PMID:16443354 all-trans-retinoic acid increases expression ISO RGD:1345750 6480464 Tretinoin results in increased expression of GPX2 mRNA CTD PMID:10498757 , PMID:17045167 all-trans-retinoic acid increases activity ISO RGD:1345750 6480464 Tretinoin results in increased activity of GPX2 protein CTD PMID:10498757 allopurinol multiple interactions ISO RGD:735351 6480464 [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of GPX2 mRNA CTD PMID:33749747 alpha-hexachlorocyclohexane increases expression EXP 6480464 alpha-hexachlorocyclohexane results in increased expression of GPX2 mRNA CTD PMID:17785943 antimonite multiple interactions ISO RGD:1345750 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GPX2 mRNA CTD PMID:32076005 aristolochic acid multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of GPX2 mRNA CTD PMID:23912714 arotinoid acid multiple interactions ISO RGD:1345750 6480464 [4-(2-(5 more ... CTD PMID:34480604 arsane increases expression ISO RGD:1345750 6480464 Arsenic results in increased expression of GPX2 mRNA CTD PMID:19945496 arsane multiple interactions ISO RGD:1345750 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of GPX2 mRNA CTD PMID:32525701 arsenic acid decreases expression ISO RGD:735351 6480464 arsenic acid results in decreased expression of GPX2 mRNA CTD PMID:19429247 arsenic atom increases expression ISO RGD:1345750 6480464 Arsenic results in increased expression of GPX2 mRNA CTD PMID:19945496 arsenic atom multiple interactions ISO RGD:1345750 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of GPX2 mRNA CTD PMID:32525701 arsenite(3-) decreases expression ISO RGD:735351 6480464 arsenite results in decreased expression of GPX2 mRNA CTD PMID:19429247 , PMID:33053406 arsenite(3-) multiple interactions ISO RGD:1345750 6480464 [sodium arsenite results in increased abundance of arsenite] which results in increased expression of GPX2 mRNA CTD PMID:32076005 atazanavir sulfate multiple interactions ISO RGD:1345750 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GPX2 mRNA, [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of GPX2 mRNA CTD PMID:32152650 , PMID:33819548 atazanavir sulfate decreases expression ISO RGD:1345750 6480464 Atazanavir Sulfate results in decreased expression of GPX2 mRNA CTD PMID:32152650 azathioprine increases expression ISO RGD:1345750 6480464 Azathioprine results in increased expression of GPX2 mRNA CTD PMID:18222062 Bardoxolone methyl affects expression ISO RGD:1345750 6480464 bardoxolone methyl affects the expression of GPX2 mRNA CTD PMID:34480604 benzalkonium chloride increases expression ISO RGD:735351 6480464 Benzalkonium Compounds results in increased expression of GPX2 mRNA CTD PMID:30171875 benzo[a]pyrene increases expression ISO RGD:1345750 6480464 Benzo(a)pyrene results in increased expression of GPX2 mRNA CTD PMID:15735009 benzo[a]pyrene decreases expression ISO RGD:1345750 6480464 Benzo(a)pyrene results in decreased expression of GPX2 mRNA CTD PMID:32234424 benzo[a]pyrene decreases methylation ISO RGD:1345750 6480464 Benzo(a)pyrene results in decreased methylation of GPX2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:735351 6480464 Benzo(a)pyrene results in increased expression of GPX2 mRNA CTD PMID:25908611 benzo[a]pyrene decreases expression ISO RGD:735351 6480464 Benzo(a)pyrene results in decreased expression of GPX2 mRNA CTD PMID:22228805 benzo[a]pyrene multiple interactions ISO RGD:1345750 6480464 Benzo(a)pyrene inhibits the reaction [glucoraphanin results in increased expression of GPX2 mRNA] CTD PMID:20868228 beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of GPX2 mRNA, beta-Naphthoflavone results in increased expression of GPX2 protein CTD PMID:19389873 more ... beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GPX2 mRNA CTD PMID:18164116 , PMID:20045035 bifenthrin increases expression ISO RGD:735351 6480464 bifenthrin results in increased expression of GPX2 mRNA CTD PMID:26071804 bifenthrin decreases expression ISO RGD:735351 6480464 bifenthrin results in decreased expression of GPX2 mRNA CTD PMID:27916261 bis(2-chloroethyl) sulfide increases expression ISO RGD:1345750 6480464 Mustard Gas results in increased expression of GPX2 mRNA CTD PMID:25102026 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GPX2 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:735351 6480464 bisphenol A results in increased expression of GPX2 mRNA CTD PMID:34585602 bisphenol A multiple interactions EXP 6480464 Resveratrol analog inhibits the reaction [bisphenol A results in decreased expression of GPX2 mRNA] CTD PMID:34067838 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GPX2 mRNA CTD PMID:34067838 , PMID:34947998 bisphenol A affects expression ISO RGD:1345750 6480464 bisphenol A affects the expression of GPX2 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:735351 6480464 bisphenol A results in decreased expression of GPX2 mRNA CTD PMID:30951980 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of GPX2 gene CTD PMID:28505145 bisphenol F affects expression ISO RGD:735351 6480464 bisphenol F affects the expression of GPX2 mRNA CTD PMID:30951980 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of GPX2 mRNA CTD PMID:17538237 buta-1,3-diene increases expression ISO RGD:735351 6480464 1, 3-butadiene results in increased expression of GPX2 mRNA CTD PMID:29038090 butanal decreases expression ISO RGD:1345750 6480464 butyraldehyde results in decreased expression of GPX2 mRNA CTD PMID:26079696 cadmium atom affects activity EXP 6480464 Cadmium affects the activity of GPX2 protein CTD PMID:16865233 cadmium dichloride affects activity EXP 6480464 Cadmium Chloride affects the activity of GPX2 protein CTD PMID:16865233 cadmium dichloride increases expression ISO RGD:735351 6480464 Cadmium Chloride results in increased expression of GPX2 mRNA CTD PMID:22677785 more ... cadmium dichloride affects expression ISO RGD:735351 6480464 Cadmium Chloride affects the expression of GPX2 mRNA CTD PMID:18974090 cadmium sulfate multiple interactions ISO RGD:1345750 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of GPX2 mRNA CTD PMID:18654764 calcitriol increases expression ISO RGD:1345750 6480464 Calcitriol results in increased expression of GPX2 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1345750 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of GPX2 mRNA CTD PMID:21592394 cannabidiol increases expression ISO RGD:1345750 6480464 Cannabidiol results in increased expression of GPX2 mRNA CTD PMID:31518892 carbamazepine affects expression ISO RGD:1345750 6480464 Carbamazepine affects the expression of GPX2 mRNA CTD PMID:24752500 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of GPX2 mRNA CTD PMID:18500788 ceric oxide decreases expression EXP 6480464 ceric oxide results in decreased expression of GPX2 mRNA CTD PMID:29463257 cerium trichloride decreases expression ISO RGD:1345750 6480464 cerous chloride results in decreased expression of GPX2 mRNA CTD PMID:28954213 CGP 52608 multiple interactions ISO RGD:1345750 6480464 CGP 52608 promotes the reaction [RORA protein binds to GPX2 gene] CTD PMID:28238834 chenodeoxycholic acid multiple interactions ISO RGD:1345750 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GPX2 mRNA more ... CTD PMID:32152650 , PMID:33819548 CHIR 99021 multiple interactions ISO RGD:1345750 6480464 [4-(2-(5 more ... CTD PMID:34480604 chloroprene increases expression ISO RGD:735351 6480464 Chloroprene results in increased expression of GPX2 mRNA CTD PMID:23125180 chlorpyrifos affects expression EXP 6480464 Chlorpyrifos affects the expression of GPX2 mRNA CTD PMID:19440498 chlorpyrifos increases expression ISO RGD:735351 6480464 Chlorpyrifos results in increased expression of GPX2 mRNA CTD PMID:32602772 cholesterol multiple interactions EXP 6480464 [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of GPX2 mRNA CTD PMID:26606054 choline multiple interactions ISO RGD:735351 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GPX2 mRNA CTD PMID:20938992 chromium(6+) multiple interactions ISO RGD:735351 6480464 [Arsenates co-treated with chromium hexavalent ion] results in increased expression of GPX2 mRNA CTD PMID:19895865 cisplatin increases expression ISO RGD:735351 6480464 Cisplatin results in increased expression of GPX2 mRNA CTD PMID:24865317 cisplatin multiple interactions ISO RGD:1345750 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of GPX2 mRNA CTD PMID:27392435 cisplatin increases expression ISO RGD:1345750 6480464 Cisplatin results in increased expression of GPX2 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:735351 6480464 [Lutein co-treated with Cisplatin] results in increased expression of GPX2 mRNA CTD PMID:24865317 cobalt atom multiple interactions ISO RGD:735351 6480464 [Cobalt co-treated with Organometallic Compounds] results in increased expression of GPX2 mRNA CTD PMID:22147119 cobalt atom increases expression ISO RGD:735351 6480464 Cobalt results in increased expression of GPX2 mRNA CTD PMID:22147119 cobalt dichloride multiple interactions ISO RGD:1345750 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of GPX2 mRNA CTD PMID:18654764 cobalt dichloride decreases expression ISO RGD:1345750 6480464 cobaltous chloride results in decreased expression of GPX2 mRNA CTD PMID:19376846 cobicistat multiple interactions ISO RGD:735351 6480464 [Rifampin co-treated with Cobicistat] results in increased expression of GPX2 mRNA CTD PMID:33629115 copper atom decreases expression EXP 6480464 Copper deficiency results in decreased expression of GPX2 mRNA, Copper results in decreased expression of GPX2 mRNA CTD PMID:19497425 , PMID:30556269 copper atom increases expression EXP 6480464 Copper results in increased expression of GPX2 mRNA CTD PMID:22465980 copper(0) decreases expression EXP 6480464 Copper deficiency results in decreased expression of GPX2 mRNA, Copper results in decreased expression of GPX2 mRNA CTD PMID:19497425 , PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of GPX2 mRNA CTD PMID:22465980 cortisol multiple interactions ISO RGD:1345750 6480464 [4-(2-(5 more ... CTD PMID:34480604 CU-O LINKAGE decreases expression ISO RGD:1345750 6480464 cupric oxide results in decreased expression of GPX2 mRNA CTD PMID:32285662 cumene hydroperoxide increases reduction ISO RGD:1345750 6480464 GPX2 protein results in increased reduction of cumene hydroperoxide CTD PMID:8428933 cyclosporin A decreases expression ISO RGD:1345750 6480464 Cyclosporine results in decreased expression of GPX2 mRNA CTD PMID:20106945 more ... cyclosporin A multiple interactions ISO RGD:1345750 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of GPX2 mRNA CTD PMID:33819548 cyfluthrin decreases expression ISO RGD:1345750 6480464 cyfluthrin results in decreased expression of GPX2 mRNA CTD PMID:31330490 cylindrospermopsin increases expression ISO RGD:1345750 6480464 cylindrospermopsin results in increased expression of GPX2 mRNA CTD PMID:24921660 cypermethrin increases expression ISO RGD:735351 6480464 cypermethrin results in increased expression of GPX2 mRNA CTD PMID:21397294 cyproconazole decreases expression EXP 6480464 cyproconazole results in decreased expression of GPX2 mRNA CTD PMID:25182419 cyproconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of GPX2 mRNA CTD PMID:29038839 cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of GPX2 mRNA CTD PMID:29038839 D-glucose increases expression EXP 6480464 Glucose results in increased expression of GPX2 mRNA CTD PMID:28027979 D-glucose multiple interactions ISO RGD:1345750 6480464 Glucose inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of GPX2 protein] CTD PMID:32942007 deoxycholic acid multiple interactions ISO RGD:1345750 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GPX2 mRNA more ... CTD PMID:32152650 , PMID:33819548 diazinon affects expression EXP 6480464 Diazinon affects the expression of GPX2 mRNA CTD PMID:17452286 , PMID:19440498 diazinon increases expression EXP 6480464 Diazinon results in increased expression of GPX2 mRNA CTD PMID:19440498 diclofenac affects expression ISO RGD:1345750 6480464 Diclofenac affects the expression of GPX2 mRNA CTD PMID:24752500 diethyl maleate affects expression ISO RGD:1345750 6480464 diethyl maleate affects the expression of GPX2 mRNA CTD PMID:34480604 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO RGD:1345750 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GPX2 mRNA CTD PMID:32076005 disodium selenite increases expression ISO RGD:735351 6480464 Sodium Selenite results in increased expression of GPX2 protein CTD PMID:25187657 doramapimod increases expression ISO RGD:735351 6480464 doramapimod results in increased expression of GPX2 mRNA CTD PMID:21328587 elemental selenium decreases activity ISO RGD:735351 6480464 Selenium deficiency results in decreased activity of GPX2 protein CTD PMID:15795427 elemental selenium decreases expression ISO RGD:735351 6480464 Selenium deficiency results in decreased expression of GPX2 mRNA CTD PMID:15795427 emodin multiple interactions ISO RGD:735351 6480464 Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of GPX2 mRNA] CTD PMID:30517764 endosulfan multiple interactions ISO RGD:1345750 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of GPX2 mRNA CTD PMID:26159488 endosulfan increases expression ISO RGD:1345750 6480464 Endosulfan results in increased expression of GPX2 mRNA CTD PMID:26159488 enilconazole decreases expression ISO RGD:735351 6480464 enilconazole results in decreased expression of GPX2 mRNA CTD PMID:29451352 epoxiconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of GPX2 mRNA CTD PMID:29038839 erythromycin estolate increases expression EXP 6480464 Erythromycin Estolate results in increased expression of GPX2 mRNA CTD PMID:24412560 ethanol multiple interactions EXP 6480464 [Fish Oils co-treated with Ethanol] results in increased expression of GPX2 mRNA CTD PMID:17347304 fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA CTD PMID:18253720 , PMID:18775883 fenofibrate multiple interactions ISO RGD:735351 6480464 Fenofibrate inhibits the reaction [triptolide results in increased expression of GPX2 mRNA] CTD PMID:31241159 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of GPX2 mRNA CTD PMID:17264098 , PMID:18775883 flutamide increases expression EXP 6480464 Flutamide results in increased expression of GPX2 mRNA CTD PMID:21203749 , PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of GPX2 mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:735351 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GPX2 mRNA more ... CTD PMID:20938992 , PMID:22206623 folic acid decreases expression ISO RGD:735351 6480464 Folic Acid results in decreased expression of GPX2 mRNA CTD PMID:25629700 folpet increases expression ISO RGD:735351 6480464 folpet results in increased expression of GPX2 mRNA CTD PMID:31558096 furan increases expression EXP 6480464 furan results in increased expression of GPX2 mRNA CTD PMID:25539665 more ... genistein decreases expression ISO RGD:735351 6480464 Genistein results in decreased expression of GPX2 mRNA CTD PMID:32186404 glucobrassicin multiple interactions ISO RGD:1345750 6480464 glucobrassicin analog inhibits the reaction [glucoraphanin analog results in increased expression of GPX2 mRNA] CTD PMID:20868228 glucobrassicin decreases expression ISO RGD:1345750 6480464 glucobrassicin analog results in decreased expression of GPX2 protein CTD PMID:20868228 glucoraphanin increases expression ISO RGD:1345750 6480464 glucoraphanin analog results in increased expression of GPX2 mRNA, glucoraphanin analog results in increased expression of GPX2 protein CTD PMID:20868228 glucoraphanin multiple interactions ISO RGD:1345750 6480464 Benzo(a)pyrene inhibits the reaction [glucoraphanin results in increased expression of GPX2 mRNA], glucobrassicin analog inhibits the reaction [glucoraphanin analog results in increased expression of GPX2 mRNA] CTD PMID:20868228 glucose increases expression EXP 6480464 Glucose results in increased expression of GPX2 mRNA CTD PMID:28027979 glucose multiple interactions ISO RGD:1345750 6480464 Glucose inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of GPX2 protein] CTD PMID:32942007 glycochenodeoxycholic acid multiple interactions ISO RGD:1345750 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GPX2 mRNA more ... CTD PMID:32152650 , PMID:33819548 glycocholic acid multiple interactions ISO RGD:1345750 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GPX2 mRNA more ... CTD PMID:32152650 , PMID:33819548 glycodeoxycholic acid multiple interactions ISO RGD:1345750 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GPX2 mRNA more ... CTD PMID:32152650 , PMID:33819548 glycyrrhetinate multiple interactions ISO RGD:735351 6480464 Glycyrrhetinic Acid inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPX2 mRNA] CTD PMID:23341968 glycyrrhetinic acid multiple interactions ISO RGD:735351 6480464 Glycyrrhetinic Acid inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPX2 mRNA] CTD PMID:23341968 gold atom increases expression ISO RGD:1345750 6480464 Gold results in increased expression of GPX2 mRNA CTD PMID:25523186 gold(0) increases expression ISO RGD:1345750 6480464 Gold results in increased expression of GPX2 mRNA CTD PMID:25523186 hexadecanoic acid increases expression EXP 6480464 Palmitic Acid results in increased expression of GPX2 mRNA CTD PMID:28027979 hydrogen peroxide increases reduction ISO RGD:1345750 6480464 GPX2 protein results in increased reduction of Hydrogen Peroxide CTD PMID:8428933 hydrogen peroxide increases expression ISO RGD:1345750 6480464 Hydrogen Peroxide results in increased expression of GPX2 mRNA CTD PMID:12414654 hydrogen peroxide affects expression ISO RGD:1345750 6480464 Hydrogen Peroxide affects the expression of GPX2 mRNA CTD PMID:20044591 hydroquinone increases expression ISO RGD:1345750 6480464 hydroquinone results in increased expression of GPX2 mRNA CTD PMID:31256213 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of GPX2 mRNA CTD PMID:21396975 indole-3-methanol increases expression EXP 6480464 indole-3-carbinol results in increased expression of GPX2 mRNA CTD PMID:21203749 , PMID:24418717 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA more ... CTD PMID:22129741 , PMID:24418717 iron atom increases expression EXP 6480464 Iron deficiency results in increased expression of GPX2 mRNA CTD PMID:16629162 iron(0) increases expression EXP 6480464 Iron deficiency results in increased expression of GPX2 mRNA CTD PMID:16629162 isotretinoin increases expression ISO RGD:1345750 6480464 Isotretinoin results in increased expression of GPX2 mRNA CTD PMID:15623509 L-ascorbic acid multiple interactions ISO RGD:1345750 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPX2 mRNA more ... CTD PMID:16443354 more ... L-ascorbic acid 2-phosphate multiple interactions ISO RGD:1345750 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of GPX2 mRNA CTD PMID:34480604 L-methionine multiple interactions ISO RGD:735351 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GPX2 mRNA CTD PMID:20938992 lead(II) chloride multiple interactions ISO RGD:1345750 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of GPX2 mRNA CTD PMID:18654764 lead(II) chloride increases expression ISO RGD:735351 6480464 lead chloride results in increased expression of GPX2 mRNA CTD PMID:23503628 linoleic acid hydroperoxide increases reduction ISO RGD:1345750 6480464 GPX2 protein results in increased reduction of linoleic acid hydroperoxide CTD PMID:8428933 lipoic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in increased expression of GPX2 mRNA CTD PMID:23830814 lipopolysaccharide multiple interactions ISO RGD:735351 6480464 3, 4-dihydroxybenzohydroxamic acid inhibits the reaction [Lipopolysaccharides results in decreased expression of GPX2 mRNA] CTD PMID:25843059 lipopolysaccharide decreases expression ISO RGD:735351 6480464 Lipopolysaccharides results in decreased expression of GPX2 mRNA CTD PMID:25843059 lutein multiple interactions ISO RGD:735351 6480464 [Lutein co-treated with Cisplatin] results in increased expression of GPX2 mRNA CTD PMID:24865317 melatonin multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with oxfendazole co-treated with Melatonin] results in increased expression of GPX2 mRNA CTD PMID:20033131 menadione increases expression ISO RGD:1345750 6480464 Vitamin K 3 results in increased expression of GPX2 mRNA CTD PMID:12414654 mercaptopurine increases expression ISO RGD:1345750 6480464 Mercaptopurine results in increased expression of GPX2 mRNA CTD PMID:18222062 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of GPX2 mRNA CTD PMID:25242409 methotrexate affects response to substance ISO RGD:1345750 6480464 GPX2 protein affects the susceptibility to Methotrexate CTD PMID:16217747 methylmercury chloride decreases expression ISO RGD:1345750 6480464 methylmercuric chloride results in decreased expression of GPX2 mRNA CTD PMID:28001369 microcystin-LR increases expression ISO RGD:735351 6480464 cyanoginosin LR results in increased expression of GPX2 mRNA CTD PMID:17654400 microcystin-LR increases expression EXP 6480464 cyanoginosin LR results in increased expression of GPX2 mRNA CTD PMID:34740672 Mitotane increases expression EXP 6480464 Mitotane analog results in increased expression of GPX2 mRNA, Mitotane results in increased expression of GPX2 mRNA CTD PMID:23485034 monocrotaline multiple interactions ISO RGD:735351 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GPX2 mRNA CTD PMID:21224054 monosodium L-glutamate affects expression ISO RGD:735351 6480464 Sodium Glutamate affects the expression of GPX2 mRNA CTD PMID:25473020 monosodium L-glutamate decreases expression ISO RGD:735351 6480464 Sodium Glutamate results in decreased expression of GPX2 protein CTD PMID:25473020 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA] CTD PMID:22129741 N-methyl-N-nitrosourea increases expression EXP 6480464 Methylnitrosourea results in increased expression of GPX2 mRNA, Methylnitrosourea results in increased expression of GPX2 protein CTD PMID:18056462 N-nitrosodiethylamine multiple interactions ISO RGD:735351 6480464 [dicyclanil co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA, Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with dicyclanil] results in increased expression of GPX2 mRNA] CTD PMID:19182440 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of GPX2 mRNA CTD PMID:19638242 , PMID:25242409 N-nitrosodiethylamine multiple interactions EXP 6480464 [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA more ... CTD PMID:14656948 more ... N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of GPX2 mRNA CTD PMID:19716841 nefazodone multiple interactions ISO RGD:1345750 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of GPX2 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GPX2 mRNA CTD PMID:32152650 , PMID:33819548 nefazodone decreases expression ISO RGD:1345750 6480464 nefazodone results in decreased expression of GPX2 mRNA CTD PMID:32152650 nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of GPX2 mRNA CTD PMID:19440498 nickel atom increases expression ISO RGD:1345750 6480464 Nickel results in increased expression of GPX2 mRNA CTD PMID:25583101 nitric oxide increases expression ISO RGD:735351 6480464 Nitric Oxide deficiency results in increased expression of GPX2 mRNA CTD PMID:15878706 obeticholic acid decreases expression ISO RGD:1345750 6480464 obeticholic acid results in decreased expression of GPX2 mRNA CTD PMID:27939613 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of GPX2 mRNA CTD PMID:24120684 omeprazole multiple interactions EXP 6480464 [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA CTD PMID:22687989 orphenadrine multiple interactions EXP 6480464 [Orphenadrine co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA, [Phenobarbital co-treated with Orphenadrine] affects the expression of GPX2 mRNA CTD PMID:23665939 , PMID:23665940 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of GPX2 mRNA CTD PMID:23665939 , PMID:23665940 oxfendazole multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GPX2 mRNA more ... CTD PMID:18754104 , PMID:20033131 ozone increases expression ISO RGD:735351 6480464 Ozone results in increased expression of GPX2 mRNA CTD PMID:17095637 , PMID:23766849 ozone multiple interactions ISO RGD:735351 6480464 NFE2L2 protein affects the reaction [Ozone results in increased expression of GPX2 mRNA] CTD PMID:23766849 p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of GPX2 mRNA CTD PMID:27638505 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of GPX2 mRNA CTD PMID:25242409 paracetamol increases expression ISO RGD:735351 6480464 Acetaminophen results in increased expression of GPX2 mRNA CTD PMID:34390818 paracetamol multiple interactions ISO RGD:735351 6480464 [CAT protein affects the susceptibility to Acetaminophen] which affects the expression of GPX2 mRNA CTD PMID:34390818 paracetamol multiple interactions ISO RGD:1345750 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of GPX2 mRNA CTD PMID:33819548 paracetamol increases expression ISO RGD:1345750 6480464 Acetaminophen results in increased expression of GPX2 mRNA CTD PMID:22230336 paracetamol decreases expression ISO RGD:1345750 6480464 Acetaminophen results in decreased expression of GPX2 mRNA CTD PMID:21420995 , PMID:29067470 paraquat increases expression ISO RGD:1345750 6480464 Paraquat results in increased expression of GPX2 mRNA CTD PMID:10806356 paraquat multiple interactions ISO RGD:1345750 6480464 [Paraquat co-treated with naringenin] results in increased expression of GPX2 mRNA CTD PMID:24561720 paraquat decreases expression ISO RGD:735351 6480464 Paraquat results in decreased expression of GPX2 mRNA CTD PMID:21688324 paraquat multiple interactions ISO RGD:735351 6480464 APOD protein affects the reaction [Paraquat results in decreased expression of GPX2 mRNA] CTD PMID:21688324 paraquat affects expression ISO RGD:735351 6480464 Paraquat affects the expression of GPX2 mRNA CTD PMID:12732627 pentane-2,3-dione increases expression ISO RGD:1345750 6480464 2, 3-pentanedione results in increased expression of GPX2 mRNA CTD PMID:30710127 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of GPX2 mRNA CTD PMID:19162173 perfluorooctanoic acid multiple interactions ISO RGD:735351 6480464 [perfluorooctanoic acid co-treated with Dietary Fats more ... CTD PMID:20118188 , PMID:23626681 perfluorooctanoic acid increases expression ISO RGD:735351 6480464 perfluorooctanoic acid results in increased expression of GPX2 mRNA CTD PMID:20118188 phenobarbital multiple interactions ISO RGD:735351 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of GPX2 mRNA] CTD PMID:19482888 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of GPX2 mRNA CTD PMID:24418717 phenobarbital multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Phenobarbital] results in increased expression of GPX2 mRNA more ... CTD PMID:23665940 more ... phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of GPX2 mRNA CTD PMID:23665940 , PMID:24025784 phenobarbital increases expression ISO RGD:735351 6480464 Phenobarbital results in increased expression of GPX2 mRNA CTD PMID:19482888 phenytoin multiple interactions ISO RGD:735351 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GPX2 mRNA CTD PMID:21224054 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:18056462 phosgene affects expression ISO RGD:735351 6480464 Phosgene affects the expression of GPX2 mRNA CTD PMID:16300373 phoxim multiple interactions EXP 6480464 Vitamin E inhibits the reaction [phoxim results in increased expression of GPX2 mRNA] CTD PMID:30003487 phoxim increases expression EXP 6480464 phoxim results in increased expression of GPX2 mRNA CTD PMID:30003487 piperonyl butoxide multiple interactions EXP 6480464 Piperonyl Butoxide affects the reaction [Phenobarbital affects the expression of GPX2 mRNA], Triterpenes promotes the reaction [Piperonyl Butoxide results in increased expression of GPX2 mRNA] CTD PMID:18544911 , PMID:24025784 piperonyl butoxide affects expression EXP 6480464 Piperonyl Butoxide affects the expression of GPX2 mRNA CTD PMID:24025784 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of GPX2 mRNA CTD PMID:17498859 more ... pirinixic acid multiple interactions ISO RGD:1345750 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GPX2 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:735351 6480464 pirinixic acid results in decreased expression of GPX2 mRNA CTD PMID:17426115 pirinixic acid increases expression ISO RGD:735351 6480464 pirinixic acid results in increased expression of GPX2 mRNA CTD PMID:16985257 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of GPX2 mRNA CTD PMID:19162173 progesterone multiple interactions ISO RGD:1345750 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of GPX2 mRNA CTD PMID:17404688 progesterone affects expression ISO RGD:735351 6480464 Progesterone affects the expression of GPX2 mRNA CTD PMID:17251523 progesterone decreases expression ISO RGD:1345750 6480464 Progesterone results in decreased expression of GPX2 mRNA CTD PMID:17404688 propanal decreases expression ISO RGD:1345750 6480464 propionaldehyde results in decreased expression of GPX2 mRNA CTD PMID:26079696 prostaglandin E2 multiple interactions ISO RGD:735351 6480464 [GPX2 protein affects the activity of PTGS2 protein] which affects the metabolism of Dinoprostone, [GPX2 protein affects the expression of PTGES protein] which affects the metabolism of Dinoprostone CTD PMID:18479189 prostaglandin E2 affects secretion ISO RGD:735351 6480464 GPX2 protein affects the secretion of Dinoprostone CTD PMID:18479189 purine-6-thiol increases expression ISO RGD:1345750 6480464 Mercaptopurine results in increased expression of GPX2 mRNA CTD PMID:18222062 quercetin multiple interactions ISO RGD:1345750 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of GPX2 mRNA CTD PMID:17639512 quercetin decreases expression ISO RGD:1345750 6480464 Quercetin results in decreased expression of GPX2 mRNA CTD PMID:21632981 , PMID:30152185 quercetin increases expression EXP 6480464 Quercetin results in increased expression of GPX2 mRNA CTD PMID:18095365 quercetin increases expression ISO RGD:1345750 6480464 Quercetin results in increased expression of GPX2 mRNA CTD PMID:17210444 quercetin decreases expression ISO RGD:735351 6480464 Quercetin results in decreased expression of GPX2 mRNA CTD PMID:16455785 quercetin 3-O-beta-D-glucofuranoside multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GPX2 mRNA CTD PMID:20033131 quercetin 3-O-beta-D-glucopyranoside multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GPX2 mRNA CTD PMID:20033131 resveratrol increases expression ISO RGD:1345750 6480464 resveratrol results in increased expression of GPX2 mRNA CTD PMID:17210444 resveratrol multiple interactions ISO RGD:1345750 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPX2 mRNA CTD PMID:23557933 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of GPX2 mRNA CTD PMID:25905778 resveratrol multiple interactions EXP 6480464 [Resveratrol co-treated with Streptozocin] results in increased expression of GPX2 mRNA, Resveratrol analog inhibits the reaction [bisphenol A results in decreased expression of GPX2 mRNA] CTD PMID:25905778 , PMID:34067838 rifampicin multiple interactions ISO RGD:735351 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GPX2 mRNA, [Rifampin co-treated with Cobicistat] results in increased expression of GPX2 mRNA CTD PMID:21224054 , PMID:33629115 S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression ISO RGD:735351 6480464 Buthionine Sulfoximine results in increased expression of GPX2 mRNA CTD PMID:15878706 SB 431542 multiple interactions ISO RGD:1345750 6480464 [LDN 193189 co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of GPX2 mRNA CTD PMID:34480604 selenium atom decreases activity ISO RGD:735351 6480464 Selenium deficiency results in decreased activity of GPX2 protein CTD PMID:15795427 selenium atom decreases expression ISO RGD:735351 6480464 Selenium deficiency results in decreased expression of GPX2 mRNA CTD PMID:15795427 silicon dioxide decreases expression ISO RGD:1345750 6480464 Silicon Dioxide analog results in decreased expression of GPX2 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:1345750 6480464 Silicon Dioxide results in increased expression of GPX2 mRNA CTD PMID:25351596 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of GPX2 mRNA CTD PMID:32721576 silver atom multiple interactions ISO RGD:1345750 6480464 NFE2L2 protein affects the reaction [Silver results in increased expression of GPX2 mRNA] CTD PMID:22546375 silver atom decreases expression ISO RGD:735351 6480464 Silver results in decreased expression of GPX2 mRNA CTD PMID:19429238 silver atom increases expression ISO RGD:1345750 6480464 Silver results in increased expression of GPX2 mRNA CTD PMID:22546375 silver(0) multiple interactions ISO RGD:1345750 6480464 NFE2L2 protein affects the reaction [Silver results in increased expression of GPX2 mRNA] CTD PMID:22546375 silver(0) decreases expression ISO RGD:735351 6480464 Silver results in decreased expression of GPX2 mRNA CTD PMID:19429238 silver(0) increases expression ISO RGD:1345750 6480464 Silver results in increased expression of GPX2 mRNA CTD PMID:22546375 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of GPX2 mRNA CTD PMID:18787804 sodium arsenate increases expression ISO RGD:1345750 6480464 sodium arsenate results in increased expression of GPX2 mRNA CTD PMID:12727804 sodium arsenate multiple interactions ISO RGD:1345750 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of GPX2 mRNA CTD PMID:32525701 sodium arsenite increases expression ISO RGD:1345750 6480464 sodium arsenite results in increased expression of GPX2 mRNA CTD PMID:20886546 , PMID:23876855 sodium arsenite multiple interactions ISO RGD:1345750 6480464 [sodium arsenite results in increased abundance of arsenite] which results in increased expression of GPX2 mRNA CTD PMID:32076005 sodium arsenite decreases expression ISO RGD:1345750 6480464 sodium arsenite results in decreased expression of GPX2 mRNA CTD PMID:29301061 sodium arsenite increases expression ISO RGD:735351 6480464 sodium arsenite results in increased expression of GPX2 mRNA CTD PMID:21396911 sodium cholate multiple interactions EXP 6480464 [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of GPX2 mRNA CTD PMID:26606054 sodium dichromate increases expression ISO RGD:735351 6480464 sodium bichromate results in increased expression of GPX2 mRNA CTD PMID:22155349 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of GPX2 mRNA CTD PMID:22561333 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of GPX2 mRNA CTD PMID:25905778 sulforaphane increases expression ISO RGD:735351 6480464 sulforaphane results in increased expression of GPX2 mRNA CTD PMID:30529165 Sunset Yellow FCF multiple interactions ISO RGD:1345750 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of GPX2 mRNA CTD PMID:33819548 T-2 toxin decreases expression EXP 6480464 T-2 Toxin results in decreased expression of GPX2 mRNA CTD PMID:26141394 tert-butyl hydroperoxide increases reduction ISO RGD:1345750 6480464 GPX2 protein results in increased reduction of tert-Butylhydroperoxide CTD PMID:8428933 tert-butyl hydroperoxide decreases expression ISO RGD:1345750 6480464 tert-Butylhydroperoxide results in decreased expression of GPX2 mRNA CTD PMID:12419474 tert-butyl hydroperoxide increases expression ISO RGD:1345750 6480464 tert-Butylhydroperoxide results in increased expression of GPX2 mRNA CTD PMID:10806356 , PMID:12414654 testosterone multiple interactions ISO RGD:1345750 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of GPX2 mRNA CTD PMID:21592394 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPX2 mRNA CTD PMID:32741896 testosterone increases expression ISO RGD:1345750 6480464 Testosterone results in increased expression of GPX2 mRNA CTD PMID:21592394 Tetrachlorobisphenol A increases expression ISO RGD:1345750 6480464 tetrachlorodian results in increased expression of GPX2 mRNA CTD PMID:31326446 tetrachloroethene increases expression ISO RGD:735351 6480464 Tetrachloroethylene results in increased expression of GPX2 mRNA CTD PMID:28973375 tetrachloromethane decreases expression ISO RGD:735351 6480464 Carbon Tetrachloride results in decreased expression of GPX2 mRNA CTD PMID:23341968 tetrachloromethane increases expression ISO RGD:735351 6480464 Carbon Tetrachloride results in increased expression of GPX2 mRNA CTD PMID:31870920 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GPX2 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of GPX2 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO RGD:735351 6480464 Glycyrrhetinic Acid inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPX2 mRNA] CTD PMID:23341968 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of GPX2 mRNA CTD PMID:23411599 , PMID:25242409 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in increased expression of GPX2 mRNA, [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of GPX2 mRNA CTD PMID:23830814 titanium dioxide affects expression ISO RGD:735351 6480464 titanium dioxide affects the expression of GPX2 mRNA CTD PMID:23557971 toluene affects expression EXP 6480464 Toluene affects the expression of GPX2 mRNA CTD PMID:18653662 Tributyltin oxide increases expression ISO RGD:1345750 6480464 bis(tri-n-butyltin)oxide results in increased expression of GPX2 mRNA CTD PMID:21601586 Tributyltin oxide increases expression ISO RGD:735351 6480464 bis(tri-n-butyltin)oxide results in increased expression of GPX2 mRNA CTD PMID:21601586 Triptolide increases expression ISO RGD:735351 6480464 triptolide results in increased expression of GPX2 mRNA CTD PMID:31241159 Triptolide multiple interactions ISO RGD:735351 6480464 Fenofibrate inhibits the reaction [triptolide results in increased expression of GPX2 mRNA] CTD PMID:31241159 tris(2-butoxyethyl) phosphate increases expression ISO RGD:735351 6480464 tris(2-butoxyethyl) phosphate results in increased expression of GPX2 mRNA CTD PMID:25808963 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1345750 6480464 tris(2-butoxyethyl) phosphate affects the expression of GPX2 mRNA CTD PMID:29024780 tris(2-chloroethyl) phosphate increases expression ISO RGD:735351 6480464 tris(chloroethyl)phosphate results in increased expression of GPX2 mRNA CTD PMID:26049154 , PMID:26183808 troglitazone increases expression ISO RGD:1345750 6480464 troglitazone results in increased expression of GPX2 mRNA CTD PMID:25572481 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of GPX2 mRNA CTD PMID:24136188 valproic acid decreases expression ISO RGD:1345750 6480464 Valproic Acid results in decreased expression of GPX2 mRNA CTD PMID:29154799 valproic acid decreases methylation ISO RGD:1345750 6480464 Valproic Acid results in decreased methylation of GPX2 gene CTD PMID:29154799 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of GPX2 mRNA CTD PMID:19015723 vitamin E multiple interactions EXP 6480464 Vitamin E inhibits the reaction [phoxim results in increased expression of GPX2 mRNA] CTD PMID:30003487 XAV939 multiple interactions ISO RGD:1345750 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of GPX2 mRNA, [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPX2 mRNA CTD PMID:34480604 zinc dichloride increases expression ISO RGD:1345750 6480464 zinc chloride results in increased expression of GPX2 mRNA CTD PMID:18947441
